Current approaches in ovarian cancer vaccines
/in International Publications, Ovarian Cancer /von 2004-12-01 / Minerva Ginecol 2004 Dec;56(6):515-27Immunoregulation of dendritic and T cells by alpha-fetoprotein in patients with hepatocellular carcinoma
/in Hepatocellular Carcinoma, International Publications /von 2004-12-01 / J. Hepatol. 2004 Dec;41(6):999-1007Dendritic cell based vaccines: progress in immunotherapy studies for prostate cancer
/in International Publications, Prostate Cancer /von 2004-12-01 / J. Urol. 2004 Dec;172(6 Pt 2):2532-8Phase II study of carboplatin and whole body hyperthermia (WBH) in recurrent and metastatic cervical cancer
/in Cervical Cancer, International Publications /von 2004-12-01 / Gynecol. Oncol. 2004 Dec;95(3):680-5
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution